Design, synthesis and evaluation of pyrazole derivatives as non-nucleoside hepatitis B virus inhibitors

A series of novel pyrazole derivatives were identified as non-nucleoside HBV inhibitors via bioisosterism and pharmacophore hybrid strategy.238